Francesca Del Bufalo

3.1k total citations
78 papers, 1.2k citations indexed

About

Francesca Del Bufalo is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, Francesca Del Bufalo has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 19 papers in Immunology and 16 papers in Neurology. Recurrent topics in Francesca Del Bufalo's work include CAR-T cell therapy research (28 papers), Neuroblastoma Research and Treatments (15 papers) and Glioma Diagnosis and Treatment (14 papers). Francesca Del Bufalo is often cited by papers focused on CAR-T cell therapy research (28 papers), Neuroblastoma Research and Treatments (15 papers) and Glioma Diagnosis and Treatment (14 papers). Francesca Del Bufalo collaborates with scholars based in Italy, United States and Germany. Francesca Del Bufalo's co-authors include Franco Locatelli, Shigeki Yagyu, Valentina Hoyos, Malcolm K. Brenner, Concetta Quintarelli, Ignazio Caruana, Angela Mastronuzzi, Biagio De Angelis, Pietro Merli and Mattia Algeri and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Francesca Del Bufalo

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Del Bufalo Italy 20 478 330 269 213 182 78 1.2k
Cecilia C.S. Yeung United States 18 1.3k 2.7× 392 1.2× 365 1.4× 316 1.5× 317 1.7× 81 2.0k
Hanh Khuu United States 22 553 1.2× 575 1.7× 329 1.2× 285 1.3× 188 1.0× 44 1.5k
Swati Naik United States 16 561 1.2× 238 0.7× 272 1.0× 83 0.4× 256 1.4× 90 1.0k
Udo Holtick Germany 25 728 1.5× 337 1.0× 631 2.3× 322 1.5× 116 0.6× 87 1.9k
Susanna Harju-Baker United States 13 1.6k 3.4× 432 1.3× 398 1.5× 147 0.7× 420 2.3× 19 2.1k
Yongxian Hu China 17 485 1.0× 356 1.1× 203 0.8× 140 0.7× 106 0.6× 60 996
José Luís Fuster Spain 18 299 0.6× 255 0.8× 163 0.6× 184 0.9× 79 0.4× 60 937
Daria Pagliara Italy 21 638 1.3× 277 0.8× 685 2.5× 352 1.7× 202 1.1× 65 1.7k
Sabine Huenecke Germany 19 504 1.1× 197 0.6× 711 2.6× 143 0.7× 102 0.6× 53 1.2k
Marc L. Turner United Kingdom 24 212 0.4× 537 1.6× 571 2.1× 191 0.9× 179 1.0× 54 1.6k

Countries citing papers authored by Francesca Del Bufalo

Since Specialization
Citations

This map shows the geographic impact of Francesca Del Bufalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Del Bufalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Del Bufalo more than expected).

Fields of papers citing papers by Francesca Del Bufalo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Del Bufalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Del Bufalo. The network helps show where Francesca Del Bufalo may publish in the future.

Co-authorship network of co-authors of Francesca Del Bufalo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Del Bufalo. A scholar is included among the top collaborators of Francesca Del Bufalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Del Bufalo. Francesca Del Bufalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ioris, Maria Antonietta De, Maria Felicia Villani, F. Fabozzi, et al.. (2025). 131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the future. ESMO Open. 10(4). 104541–104541.
2.
3.
Pagliara, Daria, Valentina Bertaina, Federica Galaverna, et al.. (2024). Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation. Haematologica. 110(3). 596–607. 2 indexed citations
4.
Pinacchio, Claudia, et al.. (2024). Developing CAR T-Cell Therapies for Pediatric Solid Tumors. Pediatric Drugs. 27(1). 5–18. 1 indexed citations
5.
Bufalo, Francesca Del, Pietro Merli, Daria Pagliara, et al.. (2024). CD7.Pebl-CART for Patients with Relapsed/Refractory (r/r) T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 144(Supplement 1). 4830–4830. 1 indexed citations
6.
Shimasaki, Noriko, Elaine Coustan‐Smith, Esther W. Chan, et al.. (2024). Fratricide-resistant CD7-CAR T cells in T-ALL. Nature Medicine. 30(12). 3687–3696. 26 indexed citations
7.
Villani, Maria Felicia, Francesca Del Bufalo, Vittorio Cannatà, et al.. (2024). 131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past. Critical Reviews in Oncology/Hematology. 207. 104606–104606. 1 indexed citations
8.
Baldo, Giada Del, Francesca Del Bufalo, Claudia Pinacchio, et al.. (2023). The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors. Frontiers in Immunology. 14. 18 indexed citations
9.
Ioris, Maria Antonietta De, Francesca Del Bufalo, Giada Del Baldo, et al.. (2023). Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series. Scientific Reports. 13(1). 19295–19295. 3 indexed citations
10.
Vinti, Luciana, Daria Pagliara, Salvatore Buffardi, et al.. (2022). Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma. Pediatric Blood & Cancer. 69(4). e29557–e29557. 5 indexed citations
11.
Fusaroli, Michele, Valentina Isgrò, Paola Maria Cutroneo, et al.. (2022). Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database. Drug Safety. 45(8). 891–908. 40 indexed citations
12.
Strocchio, Luisa, Daria Pagliara, Mattia Algeri, et al.. (2021). HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. Blood Advances. 5(5). 1333–1339. 15 indexed citations
13.
Merli, Pietro, Daria Pagliara, Federica Galaverna, et al.. (2021). TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders. Blood Advances. 6(1). 281–292. 25 indexed citations
14.
Bottari, Gabriella, Pietro Merli, Claudia Bracaglia, et al.. (2021). Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children. Blood Purification. 51(5). 417–424. 11 indexed citations
15.
Ceglie, Giulia, Giada Del Baldo, Emanuele Agolini, et al.. (2020). Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas. Frontiers in Pediatrics. 8. 561487–561487. 12 indexed citations
16.
Polito, Vinicia Assunta, Gerrit Weber, Francesca Del Bufalo, et al.. (2019). Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells. Frontiers in Immunology. 10. 2717–2717. 32 indexed citations
17.
18.
Quintarelli, Concetta, Domenico Orlando, Iolanda Boffa, et al.. (2018). Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma. OncoImmunology. 7(6). e1433518–e1433518. 106 indexed citations
19.
Russo, Ida, Virginia Di Paolo, Carmelo Gurnari, et al.. (2018). Congenital Rhabdomyosarcoma: a different clinical presentation in two cases. BMC Pediatrics. 18(1). 166–166. 12 indexed citations
20.
Bufalo, Francesca Del, Andrea Carai, Lorenzo Figà-Talamanca, et al.. (2014). Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent. Journal of Translational Medicine. 12(1). 356–356. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecilia C.S. Yeung Breakdown of academic impact, for papers by Hanh Khuu Breakdown of academic impact, for papers by Swati Naik Breakdown of academic impact, for papers by Udo Holtick Breakdown of academic impact, for papers by Susanna Harju-Baker Breakdown of academic impact, for papers by Yongxian Hu Breakdown of academic impact, for papers by José Luís Fuster Breakdown of academic impact, for papers by Daria Pagliara Breakdown of academic impact, for papers by Sabine Huenecke Breakdown of academic impact, for papers by Marc L. Turner
Rankless by CCL
2026